{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:25:07Z","timestamp":1794565507715,"version":"4.9.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>\n                    Adult granulosa cell tumors (aGCTs) of the ovary are uniquely characterized by an almost ubiquitous somatic mutation in the\n                    <jats:italic toggle=\"yes\">FOXL2<\/jats:italic>\n                    gene (p.C134W). We report the first series of 7 aGCTs harboring pathogenic\n                    <jats:italic toggle=\"yes\">FGFR1<\/jats:italic>\n                    kinase domain mutations, providing a novel alternative oncogenic mechanism in these rare\n                    <jats:italic toggle=\"yes\">FOXL2<\/jats:italic>\n                    -wildtype tumors. Archival sex cord-stromal tumors that underwent targeted DNA sequencing (MSK-IMPACT, Oncopanel, and Foundation Medicine assays) were reviewed. Histopathologic and immunophenotypic features were reviewed by expert pathologists. Seven cases were identified with\n                    <jats:italic toggle=\"yes\">FGFR1<\/jats:italic>\n                    hotspot mutations (codons N546, N577, K656, and K687), 6 of which lacked the pathognomonic\n                    <jats:italic toggle=\"yes\">FOXL2<\/jats:italic>\n                    p.C134W variant. All tumors demonstrated the classic histology of aGCT (microfollicular growth, Call-Exner bodies, \u201ccoffee bean\u201d nuclei) with 5\/5 showing robust inhibin-\u03b1 positivity by immunohistochemistry. No distinct morphologic or immunophenotypic differences were found compared with conventional\n                    <jats:italic toggle=\"yes\">FOXL2<\/jats:italic>\n                    -mutant aGCTs. Clinically, most patients presented at early stage (IA) and underwent surgical management. Four patients experienced recurrent disease involving peritoneal or omental sites, but overall clinical behavior was comparable to typical aGCTs. These findings establish\n                    <jats:italic toggle=\"yes\">FGFR1<\/jats:italic>\n                    alterations as an alternative oncogenic driver in a subset of\n                    <jats:italic toggle=\"yes\">FOXL2<\/jats:italic>\n                    -wildtype aGCTs. From a diagnostic standpoint, the absence of\n                    <jats:italic toggle=\"yes\">FOXL2<\/jats:italic>\n                    p.C134W mutation does not exclude the diagnosis of aGCT when the morphology and immunoprofile are characteristic.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002473","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:02:29Z","timestamp":1761224549000},"page":"1245-1250","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["FGFR1 Mutations Are Rare Alternate Oncogenic Drivers in FOXL2-Wildtype Adult Granulosa Cell Tumors of the Ovary"],"prefix":"10.1097","volume":"49","author":[{"given":"David L.","family":"Kolin","sequence":"first","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Mata","sequence":"additional","affiliation":[{"name":"Pathology and Diagnostic Medicine, Foundation Medicine, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas I.","family":"Lin","sequence":"additional","affiliation":[{"name":"Pathology and Diagnostic Medicine, Foundation Medicine, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora Hedrick","family":"Ellenson","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Momeni-Boroujeni","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"R1-20251112","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1056\/NEJMoa0902542","article-title":"Mutation of FOXL2 in granulosa-cell tumors of the ovary","volume":"360","author":"Shah","year":"2009","journal-title":"N Engl J Med"},{"key":"R2-20251112","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cjp2.198","article-title":"Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease","volume":"7","author":"Pilsworth","year":"2021","journal-title":"J Pathol Clin Res"},{"key":"R3-20251112","doi-asserted-by":"crossref","first-page":"102201","DOI":"10.1016\/j.labinv.2024.102201","article-title":"The molecular landscape of 227 adult granulosa cell tumors of the ovary: insights into the progression from primary to recurrence","volume":"105","author":"Mich\u00e1lkov\u00e1","year":"2024","journal-title":"Lab Invest"},{"key":"R4-20251112","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/his.12747","article-title":"DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study","volume":"68","author":"Goulvent","year":"2016","journal-title":"Histopathology"},{"key":"R5-20251112","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/PAS.0000000000001232","article-title":"DICER1 and FOXL2 mutation status correlates with clinicopathologic features in ovarian Sertoli-Leydig cell tumors","volume":"43","author":"Karnezis","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R6-20251112","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1158\/1078-0432.CCR-21-3394","article-title":"Integrated analysis of ovarian juvenile granulosa cell tumors reveals distinct epigenetic signatures and recurrent TERT rearrangements","volume":"28","author":"Vougiouklakis","year":"2022","journal-title":"Clin Cancer Res"},{"key":"R7-20251112","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.5858\/arpa.2021-0385-OA","article-title":"Cystic granulosa cell tumors of the ovary: an analysis of 80 cases of an often diagnostically challenging entity","volume":"146","author":"Boyraz","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"R8-20251112","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41379-018-0007-9","article-title":"TERT promoter mutation in adult granulosa cell tumor of the ovary","volume":"31","author":"Pilsworth","year":"2018","journal-title":"Mod Pathol"},{"key":"R9-20251112","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1262\/jrd.2013-090","article-title":"Differential apoptotic and proliferative activities of wild-type FOXL2 and blepharophimosis-ptosis-epicanthus inversus syndrome (BPES)-associated mutant FOXL2 proteins","volume":"60","author":"Kim","year":"2014","journal-title":"J Reprod Dev"},{"key":"R10-20251112","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/PAS.0b013e31820a406c","article-title":"FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary","volume":"35","author":"Al-Agha","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R11-20251112","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cell.2009.11.021","article-title":"Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation","volume":"139","author":"Uhlenhaut","year":"2009","journal-title":"Cell"},{"key":"R12-20251112","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/onc.2010.541","article-title":"Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W)","volume":"30","author":"Kim","year":"2011","journal-title":"Oncogene"},{"key":"R13-20251112","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1158\/0008-5472.CAN-22-1880","article-title":"The oncogenic FOXL2 C134W mutation is a key driver of granulosa cell tumors","volume":"83","author":"Llano","year":"2023","journal-title":"Cancer Res"},{"key":"R14-20251112","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1274\/jmor.31.86","article-title":"Expression and regulation of FGF receptors in mouse granulosa cells","volume":"31","author":"Furukawa","year":"2014","journal-title":"J Mamm Ova Res"},{"key":"R15-20251112","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2527\/jas.2013-6989","article-title":"Effects of fibroblast growth factor 9 on steroidogenesis and control of FGFR2IIIc mRNA in porcine granulosa cells","volume":"92","author":"Evans","year":"2014","journal-title":"J Anim Sci"},{"key":"R16-20251112","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1530\/REP-20-0264","article-title":"FGF2\/FGFR signaling promotes cumulus-oocyte complex maturation in vitro","volume":"161","author":"Du","year":"2021","journal-title":"Reproduction"},{"key":"R17-20251112","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1439-0531.2011.01813.x","article-title":"Basic FGF promotes proliferation of ovarian granulosa cells in the laying chickens via FGFR1 and PKC pathway","volume":"47","author":"Lin","year":"2012","journal-title":"Reprod Domest Anim"},{"key":"R18-20251112","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1210\/en.2012-1003","article-title":"Effects of fibroblast growth factor 9 (FGF9) on steroidogenesis and gene expression and control of FGF9 mRNA in bovine granulosa cells","volume":"153","author":"Schreiber","year":"2012","journal-title":"Endocrinology"},{"key":"R19-20251112","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/cells8111334","article-title":"P65 targets FGFR1 to regulate the survival of ovarian granulosa cells","volume":"8","author":"Yuan","year":"2019","journal-title":"Cells"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:00:37Z","timestamp":1762927237000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002473","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]}}}